Bentham Science Logo

Contents

Current Medicinal Chemistry, Volume 19 - Number 7


Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

, 19(7): 938 - 944

G. Ranieri, G. Gadaleta-Caldarola, V. Goffredo, R. Patruno, A. Mangia, A. Rizzo, R. L. Sciorsci and C. D. Gadaleta


DOI: 10.2174/092986712799320736


mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma

, 19(7): 945 - 954

A. Guarini, C. Minoia, M. Giannoccaro, A. Rana, A. Iacobazzi, A. Lapietra, A. Raimondi, N. Silvestris, C. D. Gadaleta and G. Ranieri


DOI: 10.2174/092986712799320727



Bevacizumab in Non Small Cell Lung Cancer: Development, Current Status and Issues

, 19(7): 961 - 971

C. Sandomenico, R. Costanzo, G. Carillio, M. C. Piccirillo, A. Montanino, M. Di Maio, G. Rocco, N. Normanno, F. Perrone and A. Morabito


DOI: 10.2174/092986712799320673







MMP-2 Selectivity in Hydroxamate-Type Inhibitors

, 19(7): 1036 - 1064

P. Serra, M. Bruczko, J. M. Zapico, A. Puckowska, M. A. Garcia, S. Martin-Santamaria, A. Ramos and B. de Pascual-Teresa


DOI: 10.2174/092986712799320628





Webmaster Contact: info@benthamscience.net
Copyright © 2018 Bentham Science